Hereditary equine regional dermal asthenia

Last updated

Hereditary equine regional dermal asthenia (HERDA), also known as hyperelastosis cutis (HC), is an inherited autosomal recessive connective tissue disorder. It develops from a homozygous recessive mutation that weakens collagen fibers that allow the skin of the animal to stay connected to the rest of the animal. Affected horses have extremely fragile skin that tears easily and exhibits impaired healing. In horses with HC, the skin separates between the deep and superficial dermis. There is no cure. Most affected individuals receive an injury they cannot heal, and are euthanized. Managed breeding strategy is currently the only option for reducing the incidence of the disease.

Contents

The disease is found primarily in the American Quarter Horse, specifically in cutting horse lines. Affected horses have been found to trace to the stallion Poco Bueno, or possibly, farther back to one of his ancestors. [1] Researchers have now named four deceased Quarter Horse stallions that were carriers and produced at least one affected HERDA foal; they are Dry Doc, Doc O'Lena, Great Pine, and Zippo Pine Bar. These stallions all trace to Poco Bueno through his son and daughter Poco Pine and Poco Lena. Other breeds affected are the American Paint Horse, and the Appaloosa and any other breed registry that allows outcrossing to AQHA[ clarification needed ] horses.

HERDA is characterized by abnormal skin along the back that tears or rips easily and heals into disfiguring scars. The skin is loose, and hyper-elastic in affected horses. This collagen based abnormality affects their heart valves too and their mechanical properties are found to be inferior to native horses. [2] Symptoms typically don’t appear until the horse is subjected to pressure or injury on their back, neck or hips, usually around two years of age. However foals can show signs when injured, while other horses mature and only show signs in the joints. [3] The expression of HERDA is variable, and the phenotypic range of expression is still being determined.

After being tested, the results either show "normal", "carrier" or "affected" and can be determined by DNA testing of either a blood or hair sample.

The expected lifespan of an affected horse is 2–4 years. There is currently no cure for this disease. To prevent it from occurring, the only solution is not to breed horses who both carry the HERDA allele.

History

The disease first was recognized in 1971. Research of affected animals indicated that 95% of the identified HERDA horses have traced back to Poco Bueno on both sides of the pedigree. Some also trace to his full brother, Old Grand Dad. The remaining 5% trace to King, the sire of both horses. This may suggest that Poco Bueno could have inherited the HC mutation from his sire, with the possibility that the condition goes even further back. It is difficult to trace the condition further because no pedigrees to date completely distinguish between the lines of Poco Bueno's sire, King, and his dam, Miss Taylor; even if full records existed, it would be difficult to verify them due to their age. [4]

A disease consistent with HERDA/HC was described in the scientific literature in 1988 documenting two related affected Quarter Horses. [5] Researchers at Mississippi State University described a separation of the upper and lower dermis associated with a loose packing of collagen fibrils in a one-year-old filly with hyperelastosis cutis. [6] In 2004, clinical veterinarians at the University of California, Davis first coined the term hereditary equine regional dermal asthenia (HERDA) after examining 50 horses with stereotypical presentation of the disease. [7] Shortened and thinned collagen fibrils in the deep dermis was the significant characteristic shared among the affected skin of diseased horses.

Throughout the years, closely breeding back, or inbreeding, to the lines of Poco Bueno increased the frequency of homozygousity in the population, thus increasing the number of affected animals. The 2004 Quarter Horse News Stallion Register revealed that of the top 100 cutting horse stallions, 14 are known HERDA carriers. Today, approximately 28% of all horses of cutting horse bloodlines are carriers of HERDA.[ citation needed ]

Using DNA from the UC Davis clinical collection of HERDA samples, collaborating UC Davis geneticists searched for discreet areas of DNA that were homozygous, or identical by descent, uniquely in affected horses. UC Davis first reported successful preliminary mapping in January 2004. [8] Additional work verified the disease was inherited, rather than caused solely by environmental insult, and strongly indicated an autosomal recessive mode of inheritance. [9] In January 2007, UC Davis presented their findings at the Plant and Animal Genome Conference Equine Workshop indicating the ability to identify horses that carry HERDA. [10] A full accounting of this work, detailing the mapping and identification of a mutation in the gene coding for peptidylprolyl isomerase B, was published on May 11, 2007. [11] Concurrent with publication of these results, the Veterinary Genetics Laboratory at UC Davis began offering a genetic test to identify carriers of the disease allele.

In the spring of 2007, researchers working independently at Cornell University and at the University of California, Davis announced that a DNA test for HERDA had been developed. Over 1,500 horses were tested during the development phase of the test, which was initially available to the general public through both institutions. [12] A United States patent for the HERDA test was issued to UC Davis [13] on October 27, 2009.

Related Research Articles

American Quarter Horse American horse breed

The American Quarter Horse, or Quarter Horse, is an American breed of horse that excels at sprinting short distances. Its name is derived from its ability to outrun other horse breeds in races of a quarter mile or less; some have been clocked at speeds up to 44 mph (70.8 km/h). The development of the Quarter Horse traces to the 1600s.

Palomino Genetic color in horses

Palomino is a genetic color in horses, consisting of a gold coat and white mane and tail; the degree of whiteness can vary from bright white to yellow. Genetically, the palomino color is created by a single allele of a dilution gene called the cream gene working on a "red" (chestnut) base coat. Palomino is created by a genetic mechanism of incomplete dominance, hence it is not considered true-breeding. However, most color breed registries that record palomino horses were founded before equine coat color genetics were understood as well as they are today, therefore the standard definition of a palomino is based on the visible coat color, not heritability nor the underlying presence of the dilution gene.

American Paint Horse American breed of horse

The American Paint Horse is a breed of horse that combines both the conformational characteristics of a western stock horse with a pinto spotting pattern of white and dark coat colors. Developed from a base of spotted horses with Quarter Horse and Thoroughbred bloodlines, the American Paint Horse Association (APHA) breed registry is now one of the largest in North America. The registry allows some non-spotted animals to be registered as "Solid Paint Bred" and considers the American Paint Horse to be a horse breed with distinct characteristics, not merely a color breed.

Lethal white syndrome Medical condition

Lethal white syndrome (LWS), also called overo lethal white syndrome (OLWS), lethal white overo (LWO), and overo lethal white foal syndrome (OLWFS), is an autosomal genetic disorder most prevalent in the American Paint Horse. Affected foals are born after the full 11-month gestation and externally appear normal, though they have all-white or nearly all-white coats and blue eyes. However, internally, these foals have a nonfunctioning colon. Within a few hours, signs of colic appear; affected foals die within a few days. Because the death is often painful, such foals are often humanely euthanized once identified. The disease is particularly devastating because foals are born seemingly healthy after being carried to full term.

Glycogen-branching enzyme deficiency (GBED) is an inheritable glycogen storage disease affecting American Quarter Horses and American Paint Horses. It leads to abortion, stillbirths, or early death of affected animals. The human form of the disease is known as glycogen storage disease type IV.

Cerebellar abiotrophy Genetic condition in animals

Cerebellar abiotrophy (CA), also called cerebellar cortical abiotrophy (CCA), is a genetic neurological disease in animals, best known to affect certain breeds of horses, dogs and cats. It can also develop in humans. It develops when the neurons known as Purkinje cells, located in the cerebellum of the brain, begin to die off. These cells affect balance and coordination. They have a critical role to play in the brain. The Purkinje layer allows communication between the granular and molecular cortical layers in the cerebellum. Put simply, without Purkinje cells, an animal loses its sense of space and distance, making balance and coordination difficult. People with damage to the cerebellum can experience symptoms like unsteady gait, poor muscle control, and trouble speaking or swallowing.

Poco Bueno was a brown American Quarter Horse stallion foaled April 10, 1944. He was sired by King P-234 and out of the mare Miss Taylor who was by Old Poco Bueno. Poco Bueno was named for his maternal grandsire, and the name means pretty good in Spanish. Poco Bueno is the stallion that is linked to the genetic disease Hereditary Equine Regional Dermal Asthenia (HERDA) in stock horses.

Equine viral arteritis (EVA) is a disease of horses caused by a virus of the species Alphaarterivirus equid, an RNA virus. It is the only species in the genus Alphaarterivirus, and that is the only genus in the Equarterivirinae subfamily. The virus which causes EVA was first isolated in 1953, but the disease has afflicted equine animals worldwide for centuries. It has been more common in some breeds of horses in the United States, but there is no breed "immunity". In the UK, it is a notifiable disease. There is no known human hazard.

Junctional epidermolysis bullosa (veterinary medicine)

Junctional epidermolysis bullosa (JEB) is an inherited disorder that is also known as red foot disease or hairless foal syndrome. JEB is the result of a genetic mutation that inhibits protein production that is essential for skin adhesion. Therefore, tissues, such as skin and mouth epithelia, are affected. Blisters form over the entire body causing pain and discomfort, and open sores leave newborn foals highly susceptible to secondary infection. The condition can be categorized into two types of mutations: JEB1 and JEB2. JEB1 is found in Belgian Draft horses, as well as other related Draft breeds. In contrast, JEB2 is found in American Saddlebred horses.

Poco Lena (1949–1968) was an outstanding cutting mare, and dam of two famous Quarter horse cutting horses and stallions: Doc O'Lena and Dry Doc.

Contagious equine metritis (CEM) is a type of metritis in horses that is caused by a sexually transmitted infection. It is thus an equine venereal disease of the genital tract of horses, brought on by the Taylorella equigenitalis bacteria and spread through sexual contact. The disease was first reported in 1977, and has since been reported worldwide.

Lavender foal syndrome

Lavender foal syndrome (LFS), also called coat color dilution lethal (CCDL), is an autosomal recessive genetic disease that affects newborn foals of certain Arabian horse bloodlines. Affected LFS foals have severe neurological abnormalities, cannot stand, and require euthanasia shortly after birth. The popular name originates due to a diluted color of the foal's coat, that in some cases appears to have a purple or lavender hue. However, not all foals possess the lavender coat colour, and colouring can range from silver to light chestnut to a pale pink. Carrier horses have no clinical signs and DNA testing can determine if a horse carries the gene.

Cutaneous asthenia is a skin disorder caused by a collagen defect. Collagen is the protein that binds the cells of the dermis together. It is also called dermatoproxy, hereditary skin fragility or cutis elastica and is found in humans, cats, dogs, mink, horses, cattle and sheep. In cattle and sheep, it is called dermatosparaxis. The skin is also abnormally fragile. The skin flaps peel or slough off very easily, often without causing bleeding. This explains why cats with the condition suddenly "molt" their wings.

Urbach–Wiethe disease Rare recessive genetic disorder

Urbach–Wiethe disease is a very rare recessive genetic disorder, with approximately 400 reported cases since its discovery. It was first officially reported in 1929 by Erich Urbach and Camillo Wiethe, although cases may be recognized dating back as early as 1908.

Feline cutaneous asthenia is a rare inheritable skin disease of cats characterised by abnormal elasticity, stretching, and improper healing of the skin. Pendulous wing-like folds of skin form on the cat's back, shoulders and haunches. Even stroking the cat can cause the skin to stretch and tear. A recessive autosomal form of feline cutaneous asthenia has been identified in Siamese cats and related breeds. In the homozygous state, it is apparently lethal. Feline cutaneous asthenia is similar to the Ehlers–Danlos syndrome of humans.

Skin cancer, or neoplasia, is the most common type of cancer diagnosed in horses, accounting for 45 to 80% of all cancers diagnosed. Sarcoids are the most common type of skin neoplasm and are the most common type of cancer overall in horses. Squamous-cell carcinoma is the second-most prevalent skin cancer, followed by melanoma. Squamous-cell carcinoma and melanoma usually occur in horses greater than 9-years-old, while sarcoids commonly affect horses 3 to 6 years old. Surgical biopsy is the method of choice for diagnosis of most equine skin cancers, but is contraindicated for cases of sarcoids. Prognosis and treatment effectiveness varies based on type of cancer, degree of local tissue destruction, evidence of spread to other organs (metastasis) and location of the tumor. Not all cancers metastasize and some can be cured or mitigated by surgical removal of the cancerous tissue or through use of chemotherapeutic drugs.

Degenerative suspensory ligament desmitis, commonly called DSLD, also known as equine systemic proteoglycan accumulation (ESPA), is a systemic disease of the connective tissue of the horse and other equines. It is a disorder akin to Ehlers–Danlos syndrome being researched in multiple horse breeds. Originally thought to be a condition of overwork and old age, the disease is now recognized as hereditary and has been seen in horses of all ages, including foals. The latest research (2010) has led to the proposed renaming of the disease from DSLD to ESPA because of the systemic and hereditary components now being found.

Hoof wall separation disease

Hoof wall separation disease, (HWSD), is an autosomal recessive genetic hoof disease in horses. Research is being carried out at, among others, UC Davis School of Veterinary Medicine in Davis in California. The disease has been found in Connemara ponies and was earlier referred to as Hoof Wall Separation Syndrome, HWSS.

Ann T. Bowling American geneticist (1943–2000)

Ann Trommershausen Bowling was an American scientist who was one of the world's leading geneticists in the study of horses, conducting research in the areas of molecular genetics and cytogenetics. She was a major figure in the development of testing to determine animal parentage, first with blood typing in the 1980s and then DNA testing in the 1990s. She later became known for her studies of hereditary diseases in horses and equine coat color genetics, as well as research on horse evolution and the development of horse breeds. She studied the population genetics of feral horses, did considerable work to help preserve the Przewalski's horse, and was one of the founding members of the international project to map the horse genome. She was an adjunct professor at the University of California, Davis (UCD), and at the time of her death in 2000 was the executive associate director of the Veterinary Genetics Laboratory (VGL) there. Her unexpected death on December 8, 2000, at age 57 was attributed to a massive stroke.

Hyperkalemic periodic paralysis is a genetic disorder that occurs in horses. It is also known as Impressive syndrome, after an index case in a horse named Impressive. It is an inherited autosomal dominant disorder that affects sodium channels in muscle cells and the ability to regulate potassium levels in the blood. It is characterized by muscle hyperexcitability or weakness which, exacerbated by potassium, heat or cold, can lead to uncontrolled shaking followed by paralysis.

References

  1. ↑ "HERDA Traces to Poco Bueno". Archived from the original on 2007-02-07. Retrieved 2007-02-08.
  2. ↑ Brinkman, Erin L.; Weed, Benjamin C.; Patnaik, Sourav S.; Brazile, Bryn L.; Centini, Ryan M.; Wills, Robert W.; Olivier, Bari; Sledge, Dodd G.; Cooley, Jim (2017-03-01). "Cardiac findings in Quarter Horses with heritable equine regional dermal asthenia". Journal of the American Veterinary Medical Association. 250 (5): 538–547. doi:10.2460/javma.250.5.538. ISSN   1943-569X. PMID   28207320.
  3. ↑ Have you Heard of HERDA accessed on July 10, 2007
  4. ↑ "Inherited Quarter Horse disease traces to Poco Bueno." "HERDA". Archived from the original on 2007-02-07. Retrieved 2007-02-08.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  5. ↑ Hardy MH, Fisher KR, Vrablic OE, et al. (August 1988). "An inherited connective tissue disease in the horse". Laboratory Investigation. 59 (2): 253–62. PMID   3404977.
  6. ↑ Brounts SH, Rashmir-Raven AM, Black SS (August 2001). "Zonal dermal separation: a distinctive histopathological lesion associated with hyperelastosis cutis in a Quarter Horse". Veterinary Dermatology. 12 (4): 219–24. doi:10.1046/j.0959-4493.2001.00256.x. PMID   11493407.
  7. ↑ White SD, Affolter VK, Bannasch DL, et al. (August 2004). "Hereditary equine regional dermal asthenia ("hyperelastosis cutis") in 50 horses: clinical, histological, immunohistological and ultrastructural findings". Veterinary Dermatology. 15 (4): 207–17. doi:10.1111/j.1365-3164.2004.00402.x. PMID   15305927.
  8. ↑ Homozygosity mapping of the HERDA locus in horse. http://www.intl-pag.org/12/abstracts/P5n_PAG12_695.html Archived 2011-06-03 at the Wayback Machine
  9. ↑ Tryon, Robert C.; White, Stephen D.; Famula, Thomas R.; Schultheiss, Patricia C.; Hamar, Dwayne W.; Bannasch, Danika L. (March 2005). "Inheritance of hereditary equine regional dermal asthenia in Quarter Horses". American Journal of Veterinary Research. 66 (3): 437–442. doi:10.2460/ajvr.2005.66.437. PMID   15822588.
  10. ↑ Genetic identification of horses that carry hereditary equine regional dermal asthenia (HERDA). http://www.intl-pag.org/15/abstracts/PAG15_P05o_600.html Archived 2011-06-03 at the Wayback Machine
  11. ↑ Tryon RC, White SD, Bannasch DL (July 2007). "Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse". Genomics. 90 (1): 93–102. doi: 10.1016/j.ygeno.2007.03.009 . PMID   17498917.
  12. ↑ Sellnow, Les. "HERDA: DNA Tests Available for Disfiguring Skin Disease". The Horse. Online News. Retrieved 2007-05-31.
  13. ↑ Bannasch; et al. (2009). "Methods for detecting a cyclophilin B SNP associated with HERDA" . Retrieved September 2, 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.